Percheron Therapeutics (AU:PER) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Percheron Therapeutics’ director Charmaine Gittleson has increased her indirect stake in the company by purchasing an additional 1,666,666 fully paid ordinary shares, bringing her total to 2,399,999 shares. This move signals potential confidence in the company’s future prospects, likely interesting investors and market watchers.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
